US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist
  • 2.380
  • -0.010-0.42%
Close May 29 16:00 ET
  • 2.500
  • +0.120+5.04%
Post 19:52 ET
62.58MMarket Cap-2245P/E (TTM)

About LAVA Therapeutics Company

LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.

Company Profile

SymbolLVTX
Company NameLAVA Therapeutics
Listing DateMar 25, 2021
Issue Price15.00
Founded2016
CEOMr. Stephen A. Hurly
MarketNASDAQ
Employees35
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressYalelaan 62
CityUtrecht
ProvinceNoord-Brabant
CountryNetherlands (the)
Zip Code3584 CM
Phone31-85-016-31-00
Websitehttp://www.lavatherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Stephen A. Hurly
  • Director, President and Chief Executive Officer
  • 814.40K
  • Fred M. Powell
  • Chief Financial Officer
  • --
  • Dr. Ton Adang, PhD
  • Chief Development Officer
  • --
  • Dr. Charles Morris, M.R.C.P.
  • Chief Medical Officer
  • --
  • Dr. Hans van der Vliet, M.D.,PhD
  • Chief Scientific Officer
  • --
  • Dr. Kapil Dhingra, M.B.B.S.
  • Chairman of the Board
  • 82.63K
  • Mary E. Wadlinger
  • Independent Director
  • 40.00K
  • Christy J. Oliger
  • Independent Director
  • 37.85K
  • Dr. Peter A. Kiener, D.Phil.
  • Independent Director
  • 39.00K
  • James Julian Noble, M.A.
  • Independent Director
  • 52.50K
  • Dr. Jay T. Backstrom, M.D.,M.P.H.
  • Independent Director
  • 47.00K
  • Karen J. Wilson
  • Independent Director
  • 55.00K
  • Amy Garabedian
  • General Counsel and Corporate Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg